AUTH/3007/12/17: Director v Vifor Fresenius (Velphoro) — clinical trial disclosure review outwith scope (No breach) | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/3007/12/17
Parties	Director v Vifor Fresenius
Topic	Clinical trial disclosure (Velphoro)
Complaint received	20 December 2017
Completed	06 March 2018
Applicable Code year	2016
Decision	No breach
Scope	Outwith the scope of the Code
Clauses cited	Outwith the scope of the Code
Additional sanctions	Not stated

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

The PMCPA Director reviewed a matter relating to clinical trial disclosure for Velphoro involving Vifor Fresenius.
The review was assessed under the ABPI Code of Practice (Applicable Code year: 2016).
The matter was determined to be outwith the scope of the Code.

⚖️

⌄

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →